L. Casali (Terni, Italy), A. Sorete Arbore (Iasi, Romania)
Clinical efficacy of once a day linezolid and azithromycin in the treatment of multi-drug resistant tuberculosis
S. Agarwal (Varanasi, Uttar Pradesh, India)
|   |
Nitric oxide, TNF-α and IFN-γ receptor in MDR-TB patients: a follow-up study
A. Diwakar, M. Sharma, M. Bose, S. N. Gaur (Delhi, India)
|  |
RpoB and katG mutations as an epidemiologic markers of multi-drug-resistant M. tuberculosis strains isolated in Kyrgyz Republic
J. Isakova, Z. Goncharova, A. Usupopova, J. Kojomkulov, A. Aldashev (Bishkek, Kyrgyzstan)
| |
Long-term treatment outcomes in multidrug-resistant tuberculosis (MDR-TB)
R. Prasad, S. K. Verma, S. Verma, A. Jain (Lucknow, India)
| |
Concomitant MDR-TB and candidiasis
S. Iglikova, A. Alenova (Almaty, Kazakhstan)
| |
Current tuberculosis patterns in a changing European union
D. Falzon, F. Ait-Belghiti (Saint-Maurice, France)
| |
Identifying pulmonary tuberculosis in emergency rooms: a decision instrument for rapid patient isolation
A. Hamzaoui, P. Lesprit, B. Maitre, L. Deforges, S. Aberrane, E. Girou, B. Housset (Creteil, France)
| |
Resistance to second-line anti-tuberculosis drugs: new drug resistant TB treatment problem
A. L. Khanin, I. B. Viktorova, S. A. Dolgikh, T. A. Jasukevitch, L. A. Malyk, A. I. Gordon (Novokuznetsk, Russian Federation)
| |